Parapneumonic Effusion and Pleural Empyema - Topical Aspects of Classification, Diagnosis and Treatment;Parapneumonischer Erguss und Pleuraempyem - Aktuelle Aspekte zu Einteilung, Diagnose und Therapie

Pneumologie

Volumn 58, Issue 2, 2004, Pages 83-91

  Kolditz, M ^a   Halank, M ^a   Hoffken G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; DIAGNOSTIC ACCURACY; FIBRINOLYSIS; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL; REVIEW; T TUBE; THORACOCENTESIS; THORACOTOMY;

EMPYEMA, PLEURAL; HUMANS; PLEURAL EFFUSION; PNEUMONIA;

EID: 1442359965     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-812528     Document Type: Review

References (59)

1. Davies CWH, Gleeson FV, Davies RJO. BTS guidelines for the management of pleural infection. Thorax 2003; 58 (Suppl 11): ii18-ii28
2. Hoyos A de, Sundaresan S. Thoracic empyema. Surg Clin N Am 2002; 82: 643-671
3. Light RW. Pleural effusion. N Engl J Med 2002; 346: 1971-1977
4. Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993; 148: 813-817
5. Bryant RE, Salmon CJ. Pleural empyema. Clin Infect Dis 1996; 22: 747-764
6. Teixeira LR, Villarino MA. Antibiotic treatment of patients with pneumonia and pleural effusion. Curr Opin Pulm Med 1998; 4: 230-234
7. Davies CWH, Kearney SE, Gleeson FV et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160: 1682-1687
8. Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108: 299-301
9. Heffner JE, Brown LK, Barbieri C et al. Pleural fluid chemical analysis in parapneumonic effusions. Am J Respir Crit Care Med 1995; 151: 1700-1708
10. Colice GL, Curtis A, Deslauriers J et al. ACCP consensus statement: Medical and surgical treatment of parapneumonic effusions. An evidence-based guideline. Chest 2000; 18: 1158-1171
11. Cheng D, Rodriguez RM, Rogers J et al. Comparision of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 1998; 114: 1368-1372
12. Kelbel C, Lorenz J. Ultraschalldiagnostik in der Pneumologie. Internist 1993; 34: 1012-1019
13. Aoe K, Hiraki A, Murakami T et al. Diagnostic significance of Interferon-γ in tuberculous pleural effusions. Chest 2003; 123: 740-744
14. Lee YCG, Rogers JT, Rodriguez RM et al. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 2001; 120: 356-361
15. Greco S, Girardi E, Masciangelo R et al. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003; 7: 777-786
16. Loddenkemper R. Diagnostik der Pleuraergüsse. Dtsch Med Wochenschr 1992; 117: 1487-1491
17. Yilmaz Turay U, Yildirim Z, Turkoz Y et al. Use of pleural fluid C-reactive protein in diagnosis of pleural effusions. Respir Med 2000; 94: 432-435
18. Wang PS, Chen YM, Hsieh YL et al. Pleural effusion and serum soluble Fas-ligand levels are elevated in different clinical conditions. Lung 2002; 180: 25-32
19. Vives M, Porcel JM, Gazques I et al. Pleural SC5b-9: A test for identifying complicated parapneumonic effusions. Respiration 2000; 67: 433-438
20. Schaberg T. Pleuraerguss bei Pneumonie. Ther Umsch 2001; 58: 604-608
21. Bartlett JG, Gorbach SL, Thadepalli H et al. Bacteriology of empyema. Lancet 1974; 1: 338-340
22. Mandal AK, Thadepalli H, Mandal AK et al. Outcome of primary empyema thoracis: Therapeutic and microbiologic aspects. Ann Thorac Surg 1998; 66: 1782-1786
23. Chen KY, Hsueh PR, Liaw YS et al. A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000; 117: 1685-1689
24. Lim TK, Chin NK. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir J 1999; 13: 514-518
25. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52: 416-421
26. Bouros D, Schiza S, Patsourakis G et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: A prospective, double-blind study. Am J Respir Crit Care Med 1997; 155: 291-295
27. Bouros D, Schiza S, Tzanakis N et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. Am Respir Crit Care Med 1999; 159: 37-42
28. Bouros D, Antoniou KM, Chalkiadakis G et al. The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. Surg Endosc 2002; 16: 151-154
29. Huang H, Chang H, Chen C et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusions or empyema. Chest 1999; 115: 751-756
30. Morgenroth A, Pfeuffer HP, Seelmann R et al. Pleural penetration of ciprofloxacin in patients with empyema thoracis. Chest 1991; 100: 406-409
31. Vaughan JJ, Basran GS. Penetration of intravenous and oral ciprofloxacin into sterile and empyemic human pleural fluid. Ann Pharmacother 1994; 28: 313-315
32. Panzer JD, Brown DC, Epstein WL et al. Clindamycin levels in various body tissues and fluids. J Clin Pharmacol New Drugs 1972; 12: 259-262
33. Makino J, Yoshiyama Y, Kanke M et al. Pharmacokinetic study of penetration of meropenem into pleural effusion in patients with pleurisy. Jpn J Antibiot 2002; 55: 77-88
34. Strahilevitz J, Lev A, Levi I et al. Experimental pneumococcal pleural empyema model: The effect of moxifloxacin. J Antimicrob Chemother 2003; 51: 665-669
35. Novick WJ. Levels of cefotaxime in body fluids and tissues: A rewiev. Rev Infect Dis 1982; 4 (Suppl): S346-S353
36. Benoni G, Arosio E, Cuzzolin L et al. Penetration of ceftriaxone into human pleural fluid. Antimicrob Agents Chemother 1986; 29: 906-908
37. Walstad RA, Hellum KB, Blika S et al. Pharmacokinetics and tissue penetration of ceftazidime: Studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid. J Antimicrob Chemother 1983; 12 (Suppl A): 275-282
38. Goonetilleke AK, Dev D, Aziz I et al. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: A study of once daily administration by intramuscular and intravenous routes. J Antimicrob Chemother 1996; 38: 969-976
39. Wildfeuer A, Ruhle KH, Bolcskei PL et al. Concentrations of ampicillin and sulbactam in serum and in various compartments of the respiratory tract of patients. Infection 1994; 22: 149-151
40. Thys JP, Vanderhoeft P, Herchuelz A et al. Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest 1988; 93: 530-532
41. Hughes CE, Scoy RE van. Antibiotic therapy of pleural empyema. Semin Respir Infect 1991; 6: 94-102
42. Soman A, Honeybourne D, Andrews J et al. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother 1999; 44: 835-838
43. Vogel F, Worth H, Adam D et al. Rationale Therapie bakterieller Atemwegsinfektionen. Chemotherapie Journal 2000; 1: 3-23
44. Frey DJM, Klapa J, Kaiser D. Spül-Drainage und Fibrinolyse zur Behandlung des metapneumonischen Pleuraempyems. Pneumologie 1999; 53: 596-604
45. Davies RJO, Gleeson FV. The diagnosis and management of pleural empyema. Curr Opin Pulm Med 1998; 4: 185-190
46. Cameron RJ. Management of complicated parapneumonic effusions and thoracic empyema. Intern Med J 2002; 32: 408-414
47. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111: 275-279
48. Tuncozgur B, Ustunsoy H, Sivrikoz MC et al. Intrapleural urokinase in the management of parapneumonic empyema: A randomised clinical trial. Int J Clin Pract 2001; 55: 658-660
49. Laisaar T, Pullerits T. Effect of intrapleural streptokinase administration on antistreptokinase antibody level in patients with loculated pleural effusions. Chest 2003; 123: 432-435
50. Light RW, Nguyen T, Mulligan ME et al. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exsudative material from loculated empyema. Lung 2000; 178: 13-18
51. Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax 2003; 58: 365-366
52. Davies CWH, Lok S, Davies RJO. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998; 157: 328-330
53. Waller DA. Thoracoscopy in management of postpneumonic pleural infections. Curr Opin Pulm Med 2002; 8: 323-326
54. Wait MA, Sharma S, Hohn J et al. A randomized trial of empyema therapy. Chest 1997; 111: 1548-1551
55. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998; 53: S65-S72
56. Cassina PC, Hauser M, Hillejan L et al. Video-assisted thoracoscopy in the treatment of pleural empyema: Stage-based management and outcome. J Thorac Cardiovasc Surg 1999; 117: 234-238
57. Loddenkemper R. Thoracoscopy - state of the art. Eur Respir J 1998; 11: 213-221
58. Solér M, Wyser C, Bolliger CT et al. Treatment of eraly parapneumonic empyema by "medical" thoracoscopy. Schweiz Med Wochenschr 1997; 127: 1748-1753
59. Lim TK. Management of parapneumonic effusion. Curr Opin Pulm Med 2001; 7: 193-197